Skip to main content
Get Alerts

FDA Drug Recalls

Every FDA drug enforcement recall Public Health Trace has on record, republished from openFDA's official drug enforcement database. See Health Alerts for current, active recalls alongside outbreaks and advisories.

Drug recall information is sourced from the FDA's structured openFDA Enforcement Reports. Newly announced recalls may appear on FDA.gov before they become available in the structured dataset. See Methodology for how Public Health Trace imports and refreshes this data.

Filters
Recall details
Location
Date range
Clear filters

Showing 12,101–12,120 of 17,974 drug recalls

Drug Recall Terminated Historical recordClass II

TESTOSTERONE CYPIONATE 150MG/ML, packaged in 5mL vials, Rx only, Well Care Compounding Pharmacy Las Vegas, NV 89121

by Well Care Compounding Pharmacy

Reason
Lack of Assurance of Sterility: FDA inspection identified GMP violations potentially impacting product quality and sterility.
Recall initiated
May 17, 2016
Reported by FDA
June 15, 2016
Distribution
NV

View recall →

Drug Recall Terminated Historical recordClass II

TESTOSTERONE CYPIONATE 10MG/ML, packaged in 5mL vials, Rx only, Well Care Compounding Pharmacy Las Vegas, NV 89121

by Well Care Compounding Pharmacy

Reason
Lack of Assurance of Sterility: FDA inspection identified GMP violations potentially impacting product quality and sterility.
Recall initiated
May 17, 2016
Reported by FDA
June 15, 2016
Distribution
NV

View recall →

Drug Recall Terminated Historical recordClass II

TESTOSTERONE CYPIONATE 100MG/ML, packaged in 5mL vials, Rx only, Well Care Compounding Pharmacy Las Vegas, NV 89121

by Well Care Compounding Pharmacy

Reason
Lack of Assurance of Sterility: FDA inspection identified GMP violations potentially impacting product quality and sterility.
Recall initiated
May 17, 2016
Reported by FDA
June 15, 2016
Distribution
NV

View recall →

Drug Recall Terminated Historical recordClass II

SUPER TRI-MIX #4, packaged in 5mL vials, Rx only, Well Care Compounding Pharmacy Las Vegas, NV 89121

by Well Care Compounding Pharmacy

Reason
Lack of Assurance of Sterility: FDA inspection identified GMP violations potentially impacting product quality and sterility.
Recall initiated
May 17, 2016
Reported by FDA
June 15, 2016
Distribution
NV

View recall →

Drug Recall Terminated Historical recordClass II

SUPER TRI-MIX #1, packaged in 5mL vials, Rx only, Well Care Compounding Pharmacy Las Vegas, NV 89121

by Well Care Compounding Pharmacy

Reason
Lack of Assurance of Sterility: FDA inspection identified GMP violations potentially impacting product quality and sterility.
Recall initiated
May 17, 2016
Reported by FDA
June 15, 2016
Distribution
NV

View recall →

Drug Recall Terminated Historical recordClass II

QUAD-MIX #4 (MOD), packaged in 5mL vials, Rx only, Well Care Compounding Pharmacy Las Vegas, NV 89121

by Well Care Compounding Pharmacy

Reason
Lack of Assurance of Sterility: FDA inspection identified GMP violations potentially impacting product quality and sterility.
Recall initiated
May 17, 2016
Reported by FDA
June 15, 2016
Distribution
NV

View recall →

Drug Recall Terminated Historical recordClass II

QUAD-MIX #2, packaged in 5mL vial, Rx only, Well Care Compounding Pharmacy Las Vegas, NV 89121

by Well Care Compounding Pharmacy

Reason
Lack of Assurance of Sterility: FDA inspection identified GMP violations potentially impacting product quality and sterility.
Recall initiated
May 17, 2016
Reported by FDA
June 15, 2016
Distribution
NV

View recall →

Drug Recall Terminated Historical recordClass II

QUAD-MIX #1, packaged in 5mL vials, Rx only, Well Care Compounding Pharmacy Las Vegas, NV 89121

by Well Care Compounding Pharmacy

Reason
Lack of Assurance of Sterility: FDA inspection identified GMP violations potentially impacting product quality and sterility.
Recall initiated
May 17, 2016
Reported by FDA
June 15, 2016
Distribution
NV

View recall →

Drug Recall Terminated Historical recordClass II

PHOSPHATIDYLCHOLINE/DEOXYCHOLIC ACID- 5%/4.75%, packaged in 10mL vials, Rx only, Well Care Compounding Pharmacy Las Vegas, NV 89121

by Well Care Compounding Pharmacy

Reason
Lack of Assurance of Sterility: FDA inspection identified GMP violations potentially impacting product quality and sterility.
Recall initiated
May 17, 2016
Reported by FDA
June 15, 2016
Distribution
NV

View recall →

Drug Recall Terminated Historical recordClass II

PHENYLEPHERINE 0.5%, packaged in 5mL vials, Rx only, Well Care Compounding Pharmacy Las Vegas, NV 89121

by Well Care Compounding Pharmacy

Reason
Lack of Assurance of Sterility: FDA inspection identified GMP violations potentially impacting product quality and sterility.
Recall initiated
May 17, 2016
Reported by FDA
June 15, 2016
Distribution
NV

View recall →

Drug Recall Terminated Historical recordClass II

MYERS' COCKTAIL, packaged in 37 mL vials, Rx only, Well Care Compounding Pharmacy Las Vegas, NV 89121

by Well Care Compounding Pharmacy

Reason
Lack of Assurance of Sterility: FDA inspection identified GMP violations potentially impacting product quality and sterility.
Recall initiated
May 17, 2016
Reported by FDA
June 15, 2016
Distribution
NV

View recall →

Drug Recall Terminated Historical recordClass II

METHYLCOBALAMIN/FOLIC ACID; 10MG/0.8MG/ML, packaged in 1mL and 5mL vials, Rx only, Well Care Compounding Pharmacy Las Vegas, NV 89121

by Well Care Compounding Pharmacy

Reason
Lack of Assurance of Sterility: FDA inspection identified GMP violations potentially impacting product quality and sterility.
Recall initiated
May 17, 2016
Reported by FDA
June 15, 2016
Distribution
NV

View recall →

Drug Recall Terminated Historical recordClass II

METHYLCOBALAMIN 5MG/ML, packaged in 1mL and 5mL vials, Rx only, Well Care Compounding Pharmacy Las Vegas, NV 89121

by Well Care Compounding Pharmacy

Reason
Lack of Assurance of Sterility: FDA inspection identified GMP violations potentially impacting product quality and sterility.
Recall initiated
May 17, 2016
Reported by FDA
June 15, 2016
Distribution
NV

View recall →

Drug Recall Terminated Historical recordClass II

METHYLCOBALAMIN 1 MG/ML, packaged in 1mL and 5mL vials, Rx only, Well Care Compounding Pharmacy Las Vegas, NV 89121

by Well Care Compounding Pharmacy

Reason
Lack of Assurance of Sterility: FDA inspection identified GMP violations potentially impacting product quality and sterility.
Recall initiated
May 17, 2016
Reported by FDA
June 15, 2016
Distribution
NV

View recall →

Drug Recall Terminated Historical recordClass II

METHYLCOBALAMIN 12.5MG/ML, packaged in 5mL vials, Rx only, Well Care Compounding Pharmacy Las Vegas, NV 89121

by Well Care Compounding Pharmacy

Reason
Lack of Assurance of Sterility: FDA inspection identified GMP violations potentially impacting product quality and sterility.
Recall initiated
May 17, 2016
Reported by FDA
June 15, 2016
Distribution
NV

View recall →

Drug Recall Terminated Historical recordClass II

M.l.C./B5/B6 25 MG/50MG/25MG/10MG/10MG/ML, packaged in 5mL vials, Rx only, Well Care Compounding Pharmacy Las Vegas, NV 89121

by Well Care Compounding Pharmacy

Reason
Lack of Assurance of Sterility: FDA inspection identified GMP violations potentially impacting product quality and sterility.
Recall initiated
May 17, 2016
Reported by FDA
June 15, 2016
Distribution
NV

View recall →

Drug Recall Terminated Historical recordClass II

MB 12/HXB 12/FA/P5P/(LIDO 0.1 %), 2MG/2MCi/20MG/6.5MG/ML, packaged in 5mL vials, Rx only, Well Care Compounding Pharmacy Las Vegas, NV 89121

by Well Care Compounding Pharmacy

Reason
Lack of Assurance of Sterility: FDA inspection identified GMP violations potentially impacting product quality and sterility.
Recall initiated
May 17, 2016
Reported by FDA
June 15, 2016
Distribution
NV

View recall →

Drug Recall Terminated Historical recordClass II

M.l.C. Methyl B12, 25 MG/50MG/25MG/1 MG/ML, packaged in 5mL vials, Rx only, Well Care Compounding Pharmacy Las Vegas, NV 89121

by Well Care Compounding Pharmacy

Reason
Lack of Assurance of Sterility: FDA inspection identified GMP violations potentially impacting product quality and sterility.
Recall initiated
May 17, 2016
Reported by FDA
June 15, 2016
Distribution
NV

View recall →

Drug Recall Terminated Historical recordClass II

M.l.C. 25MG/50MG/25MG/ML, packaged in 5mL vials, Rx only, Well Care Compounding Pharmacy Las Vegas, NV 89121

by Well Care Compounding Pharmacy

Reason
Lack of Assurance of Sterility: FDA inspection identified GMP violations potentially impacting product quality and sterility.
Recall initiated
May 17, 2016
Reported by FDA
June 15, 2016
Distribution
NV

View recall →

Drug Recall Terminated Historical recordClass II

L-GLUT/L-ARG/L-CARN; 25MG/100MG/200MG/ML, packaged in 5mL vials, Rx only, Well Care Compounding Pharmacy Las Vegas, NV 89121

by Well Care Compounding Pharmacy

Reason
Lack of Assurance of Sterility: FDA inspection identified GMP violations potentially impacting product quality and sterility.
Recall initiated
May 17, 2016
Reported by FDA
June 15, 2016
Distribution
NV

View recall →

Data last updated:

This information is republished from FDA's Recall Enterprise System through openFDA. Public Health Trace does not verify or supplement it, is not affiliated with the FDA, and does not provide medical advice -- always follow the guidance of your pharmacist, physician, or the recalling company for any medication you take. Read the full medical disclaimer.